Related Experiment Video
Updated: Jul 13, 2025

08:25
Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli
Published on: March 20, 2016
12.7K
Applications of designer phage encoding recombinant gene payloads
Daniel S Schmitt1, Sara D Siegel1, Kurt Selle1
1Biomanufacturing Training and Education Center, North Carolina State University, Raleigh, NC, USA.
Trends in Biotechnology
|October 13, 2023
Summary
Genetic engineering advances are revitalizing bacteriophage therapy for multidrug-resistant infections. This study categorizes gene payloads to explore their impact on phage-bacteria interactions for novel therapeutic applications.
Area of Science:
- Microbiology
- Genetic Engineering
- Synthetic Biology
Background:
- The rise of multidrug-resistant (MDR) infections necessitates novel therapeutic strategies.
- Bacteriophage therapy is re-emerging as a viable treatment option due to advances in genetic engineering and sequencing.
- Phages offer a promising avenue for modulating bacterial populations.
Purpose of the Study:
- To discuss and categorize recombinant gene payloads for bacteriophages.
- To explore the potential outcomes of these payloads on phage-bacteria interactions.
- To identify underexplored areas in the genetic engineering of bacteriophages for therapeutic use.
Main Methods:
- Review and categorization of heterologous gene payloads used in bacteriophage engineering.
- Analysis of potential impacts of engineered gene payloads on bacterial hosts.
- Discussion of implications for phage-bacteria interactions in therapeutic contexts.
Main Results:
- Identification of various recombinant gene payloads with potential for bacteriophage engineering.
- Categorization of these payloads based on their intended effects on bacterial targets.
- Highlighting the need for further research into payload efficacy and host interactions.
Conclusions:
- Genetic engineering of bacteriophages holds significant promise for combating MDR infections.
- Systematic categorization of gene payloads is crucial for advancing phage therapy.
- Further research is needed to fully understand and optimize the translational applications of engineered phages.
Related Concept Videos
DNA Bacteriophages
27
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
27
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
Recombinant DNA
95.6K
Overview
95.6K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K

